en
Scientific article
Open access
English

Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting

Publication date2019
Abstract

Hepatitis C virus (HCV) amongst people living in detention (PLD) is typically high in many countries including Switzerland, where it is estimated that the HCV prevalence rate is between 5.7% and 6.2%. In Switzerland, the existing screening strategy involves routine screening of PLD who indicate they are from HCV high-risk populations based on questionnaire responses upon entry to the detention center, rather than an offer to screen all PLD.

Keywords
  • Cost-Benefit Analysis
  • Hepatitis C
  • Mass Screening
  • Prisons
  • Antiviral Agents
Citation (ISO format)
GIRARDIN, François et al. Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting. In: Clinical Infectious Diseases, 2019. doi: 10.1093/cid/ciz088
Main files (1)
Article (Accepted version)
accessLevelPublic
Identifiers
ISSN of the journal1058-4838
334views
250downloads

Technical informations

Creation04/08/2019 4:14:00 PM
First validation04/08/2019 4:14:00 PM
Update time03/15/2023 4:07:07 PM
Status update03/15/2023 4:07:07 PM
Last indexation01/17/2024 5:17:57 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack